There’s still plenty of room to run to return to prior highs, but some biotech stocks and exchange traded funds are showing signs of life. That’s encouraging after what has been a surprisingly long dour run for biotech assets. For example, the VanEck Biotech ETF (BBH) is higher by 11% over the past month. Yes, [...] The post Biotech Finally Getting Its Groove Back appeared first on ETF Trends .